CarMax, Inc. Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP — Neutral
KMX PRNewsWire — December 23, 2025RADNOR, Pa. , Dec. 23, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP) — Neutral
INSP GlobeNewsWire — December 23, 2025NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit was filed on December 22, 2024 in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).
Gold Mining ETF (GDXJ) Hits New 52-Week High — Neutral
GDXJ Zacks Investment Research — December 23, 2025GDXJ just broke to a new 52-week high as as gold demand surges on Fed rate-cut expectations, central bank buying and economic uncertainties.
CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies — Positive
CRSP Zacks Investment Research — December 23, 2025CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.
Altria vs. Philip Morris: Who Leads Tobacco's Next Chapter? — Positive
MO PM Zacks Investment Research — December 23, 2025MO and PM push smoke-free growth, using pricing power, innovation and discipline to navigate declining cigarette demand and reshape tobacco's future.
Alibaba Stock Plunges 14.4% in 3 Months: Time to Buy, Sell or Hold? — Negative
BABA Zacks Investment Research — December 23, 2025BABA shares slides 14.4% in three months as profits crater despite revenue growth, with heavy AI and cloud spending testing investor patience.
Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff — Positive
BMY Seeking Alpha — December 23, 2025Bristol-Myers Squibb Company has rebounded solidly, as the market finally recognizes prior pessimism was excessive, driving renewed investor interest. Despite an estimated >60% revenue facing loss of exclusivity risks, BMY's growth portfolio delivered 18% growth in Q3 and now exceeds 50% of business mix. Robust free cash flow margins (>30%) and a 4.7% yield provide BMY investors with attractive compensation while awaiting pipeline catalysts.
Shipbuilding Stock Extends Record Highs on Trump Updates — Positive
HII Schaeffers Research — December 23, 2025Shipbuilding stock Huntington Ingalls Industries Inc (NYSE:HII) hit a fresh record high of $360.20 straight out of the gate, but was last seen trading near breakeven at $353.77.
Bitcoin 2025 Recap: BTC Up 80% YTD Despite 30% Pullback From $126K Peak — Positive
ARKB ARKW BETE BETH BITB BITC BITO BITQ BITS BITW BLKC BRRR BTCO BTCW BTF BTOP DEFI EZBC FBTC GBTC HODL IBIT SATO SPBC STCE WGMI XBTF 24/7 Wall Street — December 23, 2025Bitcoin's ( CRYPTO: BTC ) 2025 rally wasn't a straight line, which is what made it important.
Can Promises Alone Push Tesla to $2T in 2026? Here's Why Bulls Say Yes — Positive
TSLA 24/7 Wall Street — December 23, 2025Tesla (NASDAQ:TSLA ) has been unbelievably bullish in the past few months.
Copper Hits $12,000 a Ton. Time to Mine Freeport-McMoRan for More Profits? — Positive
FCX 24/7 Wall Street — December 23, 2025Freeport-McMoRan (NYSE:FCX) shares rose 3% yesterday to close at $50.64 per share, putting them just 8% below the May 2024 high of $54.86 and about 16% shy of the company's all-time high just above $59 per share that it hit back in 2008.
JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis — Positive
JNJ Zacks Investment Research — December 23, 2025Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.
Upstart's Partnerships Surge: Will it Ignite Revenue Rocket? — Positive
UPST Zacks Investment Research — December 23, 2025UPST expands partnerships with Tech CU, Peak and CAFCU, growing its AI lending network past 100 partners and widening personal, auto and HELOC offerings.
Is Amazon Stock Poised to Rally With AI Expansion in Cloud & Retail? — Positive
AMZN Zacks Investment Research — December 23, 2025AMZN stock is gaining momentum as AI investments boost AWS growth and enhance retail performance, driving revenue gains across both core businesses.
Zacks Initiates Coverage of NGVC With Outperform Recommendation — Positive
NGVC Zacks Investment Research — December 23, 2025Find out why Zacks has given Natural Grocers an "Outperform" rating, being the first on Wall Street to initiate coverage on the stock. Explore how organic retail leadership, margin-boosting strategies, and wellness-driven demand fuel its growth potential.
SHOP's Merchant Solutions Revenue Growth Picks Up: More Upside Ahead? — Positive
SHOP Zacks Investment Research — December 23, 2025Shopify's Merchant Solutions revenues surge 38.2% as GMV hits $92B, driven by B2B, Shop Pay and offline commerce strength.
Will TJX's Treasure-Hunt Appeal Boost Traffic This Holiday Season? — Positive
TJX Zacks Investment Research — December 23, 2025The TJX Companies leans on its treasure-hunt model this holiday season, with frequent new arrivals, strong branded supply, and everyday value pricing.
Pfizer says patient dies after receiving hemophilia drug in trial — Negative
PFE Reuters — December 23, 2025A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
APP vs. DUOL: Which Mobile-Tech Growth Stock Should You Consider Now? — Positive
APP DUOL Zacks Investment Research — December 23, 2025DUOL's AI-driven scalability, rapid course expansion and discounted valuation give it an edge over APP despite strong growth at both companies.
SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sprouts Farmers Market — Neutral
SFM PRNewsWire — December 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sprouts To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Sprouts between June 4, 2025 and October 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sprouts Farmers Market, Inc. ("Sprouts" or …